Ocugen Inc
For the period ended Dec 31, 2023. Filed Apr 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our properties are located in Malvern, Pennsylvania, including our corporate headquarters, which consist of approximately 28,488 square feet of leased office space, and our current GMP facility, which consists of approximately 16,401 square feet. of laboratory and future manufacturing space. Our corporate headquarters has initial terms of approximately seven years and include options to extend the leases for up to 10 years. Our current GMP facility has initial terms of seven years and includes an option to extend the lease for up to 5 years, which the Company has elected to account for since it is reasonably certain that the Company will exercise such option.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.